Nessi Claudio 4
4 · Arsanis, Inc. · Filed Nov 20, 2017
Insider Transaction Report
Form 4
Arsanis, Inc.ASNS
Nessi Claudio
Director10% Owner
Transactions
- Conversion
Common Stock
2017-11-20+41,878→ 288,560 total(indirect: See Footnote) - Conversion
Series B Convertible Preferred Stock
2017-11-20−552,487→ 0 total(indirect: See Footnote)→ Common Stock (246,682 underlying) - Conversion
Series D Convertible Preferred Stock
2017-11-20−952,497→ 0 total(indirect: See Footnote)→ Common Stock (279,079 underlying) - Conversion
Common Stock
2017-11-20+279,079→ 567,639 total(indirect: See Footnote) - Purchase
Common Stock
2017-11-20$10.00/sh+300,000$3,000,000→ 867,639 total(indirect: See Footnote) - Conversion
Series C Convertible Preferred Stock
2017-11-20−84,040→ 0 total(indirect: See Footnote)→ Common Stock (41,878 underlying) - Conversion
Common Stock
2017-11-20+246,682→ 246,682 total(indirect: See Footnote)
Footnotes (4)
- [F1]The Series B Convertible Preferred Stock converted into Common Stock on a 0.44650-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series B Convertible Preferred Stock was convertible at any time at the holder's election and automatically upon the closing at the Issuer's initial public offering. The shares had no expiration date.
- [F2]The Series C Convertible Preferred Stock converted into Common Stock on a 0.49832-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series C Convertible Preferred Stock was convertible at any time at the holder's election and automatically upon the closing at the Issuer's initial public offering. The shares had no expiration date.
- [F3]The Series D Convertible Preferred Stock converted into Common Stock on a 0.29300-for-one basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series D Convertible Preferred Stock was convertible at any time at the holder's election and automatically upon the closing at the Issuer's initial public offering. The shares had no expiration date.
- [F4]The reported securities are held of record by NeoMed Innovation V L.P. Claudio Nessi, a member of our board of directors, is the Managing Partner of NeoMed Management (Jersey) Limited, which is the Investment Manager to NeoMed Innovation V L.P. By virtue of such relationship, Dr. Nessi may be deemed to have voting and investment power with respect to the shares held by NeoMed Innovation V L.P. Dr. Nessi disclaims beneficial ownership of the shares held by NeoMed Innovation V L.P., except to the extent of its his pecuniary interest therein, if any.